Intratumoral Heterogeneity of Tumor Infiltration of Glioblastoma Revealed by Joint Histogram Analysis of Diffusion Tensor Imaging
暂无分享,去创建一个
Stephen J. Price | Florian Markowetz | Tomasz Matys | Rory J. Piper | Turid Torheim | Chao Li | F. Markowetz | R. Piper | S. Price | Chao Li | Shuo Wang | T. Torheim | Natalie R Boonzaier | Jiun-Lin Yan | T. Matys | Hongxiang Liu | Hongxiang Liu | Shuo Wang | Jiun-Lin Yan | Hyunjin Kim | Natalie R. Boonzaier | Rohitashwa Sinha | R. Sinha | Hyunjin Kim | N. R. Boonzaier
[1] R. Bammer. Basic principles of diffusion-weighted imaging. , 2003, European journal of radiology.
[2] K. Hoang-Xuan,et al. Primary brain tumours in adults , 2003, The Lancet.
[3] J. Gillard,et al. Diffusion tensor invasive phenotypes can predict progression-free survival in glioblastomas , 2013, British journal of neurosurgery.
[4] M. Lipton,et al. Utility of Diffusion Tensor Imaging in Evaluation of the Peritumoral Region in Patients with Primary and Metastatic Brain Tumors , 2014, American Journal of Neuroradiology.
[5] T. Carpenter,et al. Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. , 2006, AJNR. American journal of neuroradiology.
[6] A. Brodbelt,et al. Molecular Diagnostics , 2011, Human Genomics.
[7] Timothy Edward John Behrens,et al. Characterization and propagation of uncertainty in diffusion‐weighted MR imaging , 2003, Magnetic resonance in medicine.
[8] T. Carpenter,et al. Predicting patterns of glioma recurrence using diffusion tensor imaging , 2007, European Radiology.
[9] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[10] E. Hoving,et al. The role of diffusion tensor imaging in brain tumor surgery: A review of the literature , 2014, Clinical Neurology and Neurosurgery.
[11] M. Westphal,et al. Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] D. Pearson,et al. Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial , 2014, Acta Neuropathologica Communications.
[13] K. Hoang-Xuan,et al. Primary brain tumours in adults , 2003, The Lancet.
[14] D. Pearson,et al. Prognostic and predictive markers in recurrent high grade glioma ; results from the BR 12 randomised trial , 2014 .
[15] Michael Brady,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[16] S. Price,et al. Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study. , 2017, Radiology.
[17] P. Choyke,et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.
[18] T. A. Carpenter,et al. Tissue signature characterisation of diffusion tensor abnormalities in cerebral gliomas , 2004, European Radiology.
[19] M. McLean,et al. Multimodal MRI can identify perfusion and metabolic changes in the invasive margin of glioblastomas , 2015, Journal of magnetic resonance imaging : JMRI.
[20] S. Price,et al. Validation of a semi‐automatic co‐registration of MRI scans in patients with brain tumors during treatment follow‐up , 2016, NMR in biomedicine.
[21] S. Price,et al. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients. , 2017, Journal of neurosurgery.
[22] G. Bergers,et al. Glioblastoma: Defining Tumor Niches. , 2015, Trends in cancer.
[23] Milan Sonka,et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. , 2012, Magnetic resonance imaging.
[24] G. Reifenberger,et al. European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. , 2017, The Lancet. Oncology.
[25] Mark W. Woolrich,et al. Advances in functional and structural MR image analysis and implementation as FSL , 2004, NeuroImage.
[26] T. Carpenter,et al. Enhanced visualization and quantification of magnetic resonance diffusion tensor imaging using the p:q tensor decomposition. , 2006, The British journal of radiology.
[27] Stephen M. Smith,et al. Improved Optimization for the Robust and Accurate Linear Registration and Motion Correction of Brain Images , 2002, NeuroImage.
[28] V. P. Collins,et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics , 2013, Proceedings of the National Academy of Sciences.
[29] Jiangyang Zhang. Diffusion tensor imaging of white matter pathology in the mouse brain. , 2010, Imaging in medicine.
[30] Susan M. Chang,et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[32] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[33] Guang Yang,et al. Brain tumor classification using the diffusion tensor image segmentation (D-SEG) technique , 2014, Neuro-oncology.